Progetti FP7 coordinati da "University of dundee"
| # | ||||
|---|---|---|---|---|
| 1 | FAST-DOT COMPACT ULTRAFAST LASER SOURCES BASED ON NOVEL QUANTUM DOT STRUCTURES | 2008 | 13˙652˙372.00 | 10˙100˙000.00 |
| 2 | ITSSN Investigation into the transduction of stress signals to the nucleus | 2008 | 180˙008.00 | 180˙008.00 |
| 3 | AEROPATH "The identification, characterisation and exploitation of novel Gram-negative drug targets." | 2008 | 6˙049˙979.00 | 4˙591˙463.00 |
| 4 | NANOPORATION Ultrasound activiated nanoencapsulated targetted drug delivery and tumous cell poration | 2009 | 2˙071˙718.00 | 2˙071˙718.00 |
| 5 | M5CGS From Mutations to Metastases: Multiscale Mathematical Modelling of Cancer Growth and Spread | 2009 | 1˙680˙974.00 | 1˙680˙974.00 |
| 6 | IIIOS Integrated Interventional Imaging Operating System | 2009 | 3˙712˙345.00 | 3˙712˙345.00 |
| 7 | NEDD8ANDCRLLIGASES Regulation and Function of Cullin-Ring E3 ubiquitin ligases and the Nedd8 ubiquitin-like protein modification system | 2009 | 1˙397˙676.00 | 1˙397˙676.00 |
| 8 | POLINARES POLicy for NAtural RESouces | 2010 | 3˙365˙068.00 | 2˙678˙642.00 |
| 9 | TREATSKIN Tissue engineering to evaluate novel treatments for skin cancer and genetic disease | 2010 | 1˙999˙999.00 | 1˙999˙999.00 |
| 10 | MEDI-LASE Multifunctional MEdical DIagnostic LASEr System | 2010 | 1˙630˙569.00 | 1˙630˙569.00 |
| 11 | SENDBEAMS Semiconductor lasers for generation of non-diffracting (Bessel) beams | 2010 | 238˙289.00 | 238˙289.00 |
| 12 | ADDUCE Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects | 2010 | 3˙929˙356.00 | 2˙999˙559.00 |
| 13 | SUGABACT THE ROLE OF O-GlcNAc IN BACTERIAL SIGNAL TRANSDUCTION AND VIRULENCE | 2010 | 100˙000.00 | 100˙000.00 |
| 14 | SPWRT SPACEWIRE RT | 2011 | 674˙776.00 | 499˙996.00 |
| 15 | PLATFORM PRACTICAL LIGHT TYPES FOR RESOURCE CONSUMPTION | 2011 | 219˙284.00 | 219˙284.00 |
| 16 | NINTENDU-PULSE Novel Integrated Photonic Devices for High-Power Ultrashort Pulse Generation | 2011 | 211˙092.00 | 211˙092.00 |
| 17 | VHISSI Very High Speed Serial Interfaces | 2012 | 2˙630˙218.00 | 1˙999˙998.00 |
| 18 | REDOX Reporter models for the Evaluation of Diseases involving OXidative stress | 2012 | 2˙486˙524.00 | 2˙486˙524.00 |
| 19 | TERA Novel Compact Terahertz source based on Dual Wavelength Lasers and Photomixers | 2012 | 1˙104˙208.00 | 1˙104˙208.00 |
| 20 | GEOWAVE Geotechnical design solutions for the offshore renewable wave energy industry | 2012 | 1˙456˙241.00 | 1˙129˙100.00 |
| 21 | CELESUMOMS SUMO proteomics in C. elegans: focus on meiosis and the DNA damage response | 2012 | 209˙033.00 | 209˙033.00 |
| 22 | RELEX-AGENCIFICATION Agencies in EU Foreign Policy: RELEX-Agencification | 2012 | 100˙000.00 | 100˙000.00 |
| 23 | NEWLED Nanostructured Efficient White LEDs based on short-period superlattices and quantum dots | 2012 | 11˙760˙277.00 | 8˙400˙000.00 |
| 24 | RETRAIN REwiring the nucleus TowaRds plant ImmuNity | 2013 | 1˙393˙084.00 | 1˙393˙084.00 |
| 25 | EPISC-EU European Agencies and Epistemic Communities: Engines of European Integration in Internal Security? | 2013 | 100˙000.00 | 100˙000.00 |
| 26 | ORTHOPROTACS Design of orthogonal molecular probes targeting engineered von-Hippel Lindau (VHL) E3 ubiquitin ligase for the control of intracellular protein levels | 2013 | 221˙606.00 | 221˙606.00 |
| 27 | ABLADE Advanced Bladder cancer LAser Diagnostics and thErapy | 2013 | 2˙365˙400.00 | 2˙365˙400.00 |
| 28 | FANDAMAGE Functional characterization of FAN1, a structure-specific DNA repair nuclease | 2013 | 231˙283.00 | 231˙283.00 |
| 29 | DRUGE3CRLS Probing Druggability of Multisubunit Complexes: E3 Cullin RING Ligases | 2013 | 1˙499˙904.00 | 1˙499˙904.00 |
| 30 | PREDICTION-ADR Personalisation of tREatment In Cardiovascular disease through next generation sequencing in Adverse Drug Reactions | 2013 | 3˙897˙656.00 | 2˙999˙952.00 |
| 31 | EURO-ARCTIC LAB The European Union and the Legal Protection of Marine Biodiversity in the Arctic | 2013 | 221˙606.00 | 221˙606.00 |
| 32 | REDVA Development of hemodynamic solutions in Renal Dialysis Venous Access Failure | 2013 | 2˙635˙228.00 | 2˙635˙228.00 |
| 33 | THERACAV Harnessing Cavitation for Therapy | 2013 | 1˙453˙180.00 | 1˙453˙180.00 |
| 34 | PHOQUS PHOtonic tools for Quantitative imaging in tissUeS | 2013 | 3˙816˙691.00 | 3˙816˙691.00 |
| 35 | SITRANSPORTER Identification of molecular transporters that facilitate siRNA skin delivery | 2014 | 299˙558.00 | 299˙558.00 |
| 36 | EMRAMIR Extracellular Matrix Remodeling and Muscle Insulin Resistance: Role of Hyaluronan-CD44 Interaction | 2014 | 309˙235.00 | 309˙235.00 |
| 37 | RNF4 IN THE DDR Identifying the targets and mechanism of action of the SUMO targeted ubiquitin ligase RNF4 in response to distinct DNA lesions | 2014 | 309˙235.00 | 309˙235.00 |
| 38 | MECAR Magnetically Enhanced Controlled Axonal Regeneration | 2014 | 309˙235.00 | 309˙235.00 |
| 39 | BIOEPIC SLOPE Use of BioEngineered Plant-Integrated Cover (BioEPIC) to Enhance Slope Performance | 2014 | 100˙000.00 | 100˙000.00 |
| 40 | IFNDNA Innate immune recognition of intracellular DNA as 'stranger' and 'danger' signal | 2015 | 100˙000.00 | 100˙000.00 |
Altri progetti
L'Ente university of dundee partecipato anche in questi progetti.
- LAGOONS (2011, participant)
- LA3-NET (2011, participant)
- MERMAID (2012, participant)
- UPSTREAM (2011, participant)
- BIOMARCARE (2011, participant)
- WWWFOREUROPE (2012, participant)
- REDOX (2012, hostInstitution)
- REDOX (2012, hostInstitution)
- ADDRESS (2012, participant)
- BIOMICS (2012, participant)
- RETRAIN (2013, hostInstitution)
- RETRAIN (2013, hostInstitution)
- REVAMMAD (2013, participant)
- HICORE (2012, participant)
- LSE (2013, participant)
- OPTIMISTIC (2012, participant)
- SELFCC (2013, hostInstitution)
- SELFCC (2013, hostInstitution)
- VPH-PRISM (2013, participant)
- DRUGE3CRLS (2013, hostInstitution)
- DRUGE3CRLS (2013, hostInstitution)
- ESMART (2014, participant)
- EUROFIT (2013, participant)
- CFMATTERS (2013, participant)
- COINVENT (2013, participant)
- AGGRESSOTYPE (2013, participant)
- THERACAV (2013, hostInstitution)
- THERACAV (2013, hostInstitution)
- TRANS-FUSIMO (2014, participant)
- FUTURA (2013, participant)
- EDOCALD (2013, participant)
- GLYCOPAR (2013, participant)
- MATRICS (2014, participant)
- VM (2008, participant)
- PROSPECTS (2008, participant)
- HAMAM (2008, participant)
- VIT (2008, participant)
- RENEWALL (2008, participant)
- ACQWA (2008, participant)
- LIVEDIVERSE (2009, participant)
- TRYPOBASE (2009, participant)
- M5CGS (2009, hostInstitution)
- M5CGS (2009, hostInstitution)
- GENESIS (2009, participant)
- BIOSURF (2009, participant)
- NEDD8ANDCRLLIGASES (2009, hostInstitution)
- NEDD8ANDCRLLIGASES (2009, hostInstitution)
- NUCLEOSOME4D (2009, participant)
- TRANSFoRm (2010, participant)
- BIOSTAT-CHF (2010, participant)
- FASTID (2010, participant)
- TREATSKIN (2010, hostInstitution)
- TREATSKIN (2010, hostInstitution)
- BIOINCMED (2010, beneficiary)
- PERS (2010, participant)
- EURO-BIOIMAGING (2010, participant)
- STOP (2010, participant)
- PROFILES (2010, participant)
- FUSIMO (2011, participant)
- EPIGENESYS (2010, participant)
- DECIDE (2011, participant)
- CODIR (2011, hostInstitution)
- CODIR (2011, hostInstitution)